Evidence map›Paper›PMID 41571643›Full record

ArticleNature communications2026

ProteoAutoNet: high-throughput co-eluted protein analysis with robotics and machine learning.

Mengge Lyu, Pingping Hu, Guangmei Zhang, Kunpeng Ma, Xuedong Zhang, Pu Liu, Sai Zhang, Xiangqing Li, Rui Sun, Yi Chen and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mengge LyuSchool of Basic Medical Science, Fudan University, Shanghai, China.
Pingping HuAffiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, Westlake University, Hangzhou, Zhejiang Province, China.
Guangmei ZhangAffiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, Westlake University, Hangzhou, Zhejiang Province, China.
Kunpeng MaAffiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, Westlake University, Hangzhou, Zhejiang Province, China.
Xuedong ZhangAffiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, Westlake University, Hangzhou, Zhejiang Province, China.
Pu LiuWestlake Omics Inc., Hangzhou, Zhejiang Province, China.
Sai ZhangInstitute of Automation, Harbin University of Science and Technology, Harbin, China.
Xiangqing LiCollege of Medical Information and Artificial Intelligence, Shandong First Medical University, Jinan, China.
Rui SunAffiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, Westlake University, Hangzhou, Zhejiang Province, China. sunrui@westlake.edu.cn.ORCID 0000-0002-8484-8089
Yi ChenAffiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, Westlake University, Hangzhou, Zhejiang Province, China. chenyi@westlake.edu.cn.
Tiannan GuoSchool of Basic Medical Science, Fudan University, Shanghai, China. guotiannan@westlake.edu.cn.ORCID 0000-0003-3869-7651

Funding

Joint Funds of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (National Science Foundation of China) U24A20476
6 · The paper itself

Abstract

Co-fractionation mass spectrometry (CF-MS) enables large-scale profiling of endogenous protein-protein interactions, yet CF-MS data generation is of low throughput and therefore predictive models are often limited by the scarcity and limited diversity of high-quality training data. To address this, we present ProteoAutoNet, a robotic experimental platform integrated with a computational workflow for high-throughput CF-MS analysis. This workflow increases the throughput of sample processing from protein complex to peptide by about two times. The integrated machine learning model incorporates targeted data augmentation to expand and diversify reliable protein interaction data, thereby improving model robustness. When applied to three thyroid cell lines, the model predicted 25,173 co-eluted proteins with an AUROC of 0.78. This analysis revealed significantly upregulated proteasome and prefoldin complexes in the lung metastatic follicular thyroid carcinoma cell line FTC238 compared with the normal thyroid cell line Nthy-ori 3-1. Notably, we identified a protein interaction between TGM2 and HK1 that was significantly upregulated in the papillary thyroid carcinoma cell line TPC-1. ProteoAutoNet provides an improved framework for investigating protein-protein interactions and uncovering interactions.

Indexed as

High-Throughput Screening AssaysMachine LearningMass SpectrometryProteomicsRoboticsCell Line, TumorHumansProteasome Endopeptidase ComplexProtein Interaction MappingThyroid NeoplasmsProteasome Endopeptidase Complex

Identifiers

PMID41571643
PMCPMC12929803

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.